While Liminatus Pharma Inc has overperformed by 17.25%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, LIMN fell by -92.49%, with highs and lows ranging from $33.66 to $0.61, whereas the simple moving average fell by -87.78% in the last 200 days.
Analysis of Liminatus Pharma Inc (LIMN)
Liminatus Pharma Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. Taking into account the quick ratio of the company, currently set at 0.42, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and LIMN has an average volume of 1.29M. On a monthly basis, the volatility of the stock is set at 14.55%, whereas on a weekly basis, it is put at 23.34%, with a loss of -20.49% over the past seven days.
How Do You Analyze Liminatus Pharma Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 79.47%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 1.34% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
